Trasis wins prestigious “Trends Gazelles Ambassador” award for large companies in the Province of Liège

Trasis has just been awarded the prestigious title of “Trends Gazelles Ambassador” for large companies in the Province of Liège at the gala evening held at the Théâtre de Liège. Trasis tops the Trends Gazelles rankings for its province.

The Trends Gazelle title is recognised in the business world due to its national reputation and regional recognition. The selection of Trends Gazelles is established objectively on the basis of growth figures published by each company with the National Bank: Growth in added value over the last 5 accounting years, Growth in staff and Growth in cash flow, over the period 2019-2023.

It is also a strong motivation to continue pushing boundaries to improve the accessibility and precision of nuclear medicine in the diagnosis and treatment of cancer and degenerative diseases, ensuring they are no longer synonymous with suffering.

Today, Trasis is:

380 jobs created over 20 years
30% average growth over the last 5 years
More than 4 million patients worldwide having benefited from better healthcare in 2024, thanks to the solutions developed and manufactured by Trasis
100 colleagues dedicated to Research & Development
Ambitious projects to cover the nuclear medicine value chain even more comprehensively — from the formulation of active substances to drug manufacturing and the administration of medicines to patients

“At Trasis, we envision a future where cancer and neurodegenerative diseases are no longer synonymous with suffering. We are constantly innovating to make nuclear medicine more accessible and precise in the diagnosis and treatment of these diseases. Present in over 60 countries, we are proud to play a key role in global healthcare while contributing to the industrial redevelopment of our region and the creation of high-quality jobs,” explains Gauthier Philippart, CEO of Trasis.

A victory that rightfully belongs to the entire team!

Related contents

2024: a record-breaking year for Trasis

Trasis Innovation Newsletter - March 2025